Hyperliquid Strategies (NASDAQ:PURR) Shares Gap Up - Time to Buy?

Key Points

• Price action: Shares gapped up premarket from $4.95 to $5.18 but last traded at $4.77 on volume of 981,441 shares.
• Analyst outlook: Mixed coverage — Cantor Fitzgerald and Chardan raised targets (to $6.00 and $8.45) with Overweight/Buy ratings while Weiss initiated a Sell; the consensus rating is Hold with an average price target of $7.23.
• Company fundamentals: Hyperliquid is a digital-asset treasury focused on the HYPE token, with a market cap of $612.41M, a negative PE of -0.54, Q EPS of ($7.43) on $0.5M revenue, and about 9.45% institutional ownership.

Hyperliquid Strategies Inc (NASDAQ:PURR - Get Free Report) gapped up before the market opened on Monday . The stock had previously closed at $4.95, but opened at $5.18. Hyperliquid Strategies shares last traded at $4.77, with a volume of 981,441 shares.

Wall Street Analyst Weigh In

A number of research firms have recently commented on PURR. Cantor Fitzgerald increased their price objective on Hyperliquid Strategies from $5.00 to $6.00 and gave the company an "overweight" rating in a report on Thursday, February 12th. Wall Street Zen raised Hyperliquid Strategies to a "hold" rating in a report on Saturday, February 21st. Chardan Capital increased their price target on shares of Hyperliquid Strategies from $8.15 to $8.45 and gave the company a "buy" rating in a research note on Thursday, February 12th. Finally, Weiss Ratings initiated coverage on shares of Hyperliquid Strategies in a report on Monday, March 2nd. They set a "sell (e)" rating on the stock. Two equities research analysts have rated the stock with a Buy rating and one has given a Sell rating to the company. Based on data from MarketBeat.com, the stock presently has an average rating of "Hold" and a consensus price target of $7.23.

Hyperliquid Strategies Stock Down 0.2%

The firm has a market capitalization of $612.41 million, a PE ratio of -0.54 and a beta of 1.58.

Hyperliquid Strategies (NASDAQ:PURR - Get Free Report) last posted its earnings results on Wednesday, February 11th. The company reported ($7.43) earnings per share for the quarter. The firm had revenue of $0.50 million during the quarter.

Institutional Investors Weigh In On Hyperliquid Strategies

Large investors have recently modified their holdings of the company. Boothbay Fund Management LLC acquired a new position in shares of Hyperliquid Strategies in the 4th quarter valued at $40,000. XTX Topco Ltd acquired a new stake in Hyperliquid Strategies during the 4th quarter worth $48,000. Squarepoint Ops LLC purchased a new position in Hyperliquid Strategies during the 4th quarter worth $73,000. Millennium Management LLC purchased a new position in Hyperliquid Strategies during the 4th quarter worth $87,000. Finally, Ikarian Capital LLC acquired a new position in Hyperliquid Strategies in the fourth quarter valued at $107,000. 9.45% of the stock is owned by institutional investors and hedge funds.

Hyperliquid Strategies Company Profile

Hyperliquid Strategies Inc is a digital asset treasury company whose primary focus is to maximize shareholder value through accumulating HYPE, the native token of Hyperliquid, a high-performance blockchain custom-built to house all of finance. Hyperliquid Strategies Inc, formerly known as Sonnet BioTherapeutics Holdings Inc, is based in NEW YORK.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.